Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer.
de Wit D, Gelderblom H, Sparreboom A, den Hartigh J, den Hollander M, König-Quartel JM, Hessing T, Guchelaar HJ, van Erp NP. de Wit D, et al. Among authors: hessing t. Cancer Chemother Pharmacol. 2014 Jan;73(1):87-96. doi: 10.1007/s00280-013-2322-7. Epub 2013 Oct 23. Cancer Chemother Pharmacol. 2014. PMID: 24149944
A validated assay for the simultaneous quantification of six tyrosine kinase inhibitors and two active metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
van Erp NP, de Wit D, Guchelaar HJ, Gelderblom H, Hessing TJ, Hartigh Jd. van Erp NP, et al. Among authors: hessing tj. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 15;937:33-43. doi: 10.1016/j.jchromb.2013.08.013. Epub 2013 Aug 17. J Chromatogr B Analyt Technol Biomed Life Sci. 2013. PMID: 24013127